News

< Back

AFAR in the News: Austad, Barzilai, and Longo comment on the Oldest Incoming President in the Washington Post

AFAR Scientific Director Steven Austad, Deputy Scientific Director Nir Barzilai, and 1998 AFAR Research Grant for Junior Faculty awardee and 2013 Vincent Cristofalo Rising Star in Aging Research Award recipient Valter Longo lent insights to a January 18 article exploring the health of the incoming president in The Washington Post.

Trump’s health: What we could expect with the oldest incoming president” explores the potential impact of stress, lifestyle, genetics, and age-related diseases on Donald Trump’s current health.

Early in the article, Austad addresses the relationship between stress and health:

Given that the 45th president will be exposed to extraordinary stress levels, what else could affect his health and capabilities to respond to the challenges of office?
“I think the main thing is that the future is a lot less predictable when you’re 70 than when you’re 40 or 50,” said Steve Austad, scientific director of the American Federation for Aging Research. “He could be fine 10 years after his presidency, or he could be in bad shape a year from now.”

Later, Barzilai explains how age-related diseases and genetics can impact longevity:

But research shows that the chances of acquiring three diseases simultaneously rises ten-fold between ages 70 and 80, then ten-fold again during the following decade of life, said Nir Barzilai, director of the Institute for Aging Research at the Albert Einstein College of Medicine in New York.
“I think we all realize that humans age at different rates,” Barzilai said. “Seventy means nothing to me. It can be very young, and it can be very old.”
Barzilai said his first question would be how long Trump’s parents lived, particularly his mother. Eighty-five of every 100 centenarians are female, and the influence of long-lived women’s genes on their children is evident, he said.

Longo lends insights on family history and risk for Alzheimer’s:

The risk of Alzheimer’s, which eventually afflicted the second-oldest incoming president, Ronald Reagan, doubles every five years after age 60, said Valter Longo, professor of gerontology at the University of Southern California’s Leonard Davis School of Gerontology. Trump’s family history puts him at greater risk, though.

Read the full article here.

Steven Austad, PhD, is a Distinguished Professor and Department Chair at the University of Alabama, Birmingham.

Nir Barzilai, MD, is the Director of the Institute for Aging Research at Albert Einstein College of Medicine and a two-time AFAR grant recipient.

Valter Longo, PhD, is the Edna M. Jones Professor of Gerontology and a Professor of Biological Sciences at the University of Southern California, Davis.


For more on theories of aging, age-related diseases, and healthy lifestyle, visit AFAR’s InfoAging center here.

More Recent News

View All News >
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Grantee in the News: Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Grantee in the News:  Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President